UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                           Washington, D. C. 20549
                                 FORM 10-QSB


(x )   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
       EXCHANGE ACT OF 1934

       For the quarterly period ended June 30, 2001
                                      --------------

(  )   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES
       EXCHANGE ACT OF 1934

       For the transition period from ___________ to ______________

       Commission File number  000-26119
                               -----------

                         ALTRIMEGA HEALTH CORPORATION
       ---------------------------------------------------------------
              (Exact name of registrant as specified in charter)

       Nevada                                          87-0631750
-------------------------------                      -----------------
(State or other jurisdiction of                      (I.R.S. Employer
incorporation or organization)                       Identification No.)


 3672 East Cove Point Drive,  Salt Lake City, Utah               84109
---------------------------------------------------          ------------
(Address of principal executive offices)                      (Zip Code)


                               1- 801-278-8000
                           -----------------------
              Registrant's telephone number, including area code


                ----------------------------------------------
            (Former name, former address, and former fiscal year,
                        if changed since last report.)

Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), Yes [x ]  No [  ] and (2) has
been subject to such filing requirements for the past 90 days. Yes [x ] No[  ]

                    APPLICABLE ONLY TO CORPORATE ISSUERS:

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the last practicable date

                  Class                  Outstanding as of June 30, 2001
           ----------------------        -------------------------------
           Common  Stock, $0.001                22,020,000


                                     -1-
<PAGE>


                                    INDEX

                                                                  Page
                                                                  Number
                                                                  ------
PART I.

   ITEM 1.   Financial Statements (unaudited).........................3

             Balance Sheets...........................................4
             June 30, 2001 and December 31, 2000

             Statements of Operations
             Three and six months ended June 30, 200 and 2000.........5
             and the period from September 8, 1998 to June 30, 2001

             Statements of Cash Flows
             Six months ended June 30, 2001 and 2000..................6
             and the period from September 8, 1998 to June 30, 2001

             Notes to Financial Statements............................7

ITEM 2.      Management's Discussion and Analysis or Plan
             of Operations...........................................10

   PART II.  Other Information.......................................11

             Signatures..............................................11


                                     -2-
<PAGE>



PART I - FINANCIAL INFORMATION

______________________________________________________________________________

                         ITEM 1. FINANCIAL STATEMENTS
______________________________________________________________________________




The accompanying balance sheets of Altrimega Health Corporation (development
stage company) at June 30, 2001 and December 31, 2000, and the statements of
operations and cash flows for the three and six months ended June 30, 2001 and
2000 and the period from September 8, 1998 to June 30, 2001, have been
prepared by the Company's management and they do not include all information
and notes to the financial statements necessary for a complete presentation of
the financial position, results of operations, cash flows, and stockholders'
equity in conformity with generally accepted accounting principles.  In the
opinion of management, all adjustments considered necessary for a fair
presentation of the results of operations and financial position have been
included and all such adjustments are of a normal recurring nature.

Operating  results for the quarter ended June 30, 2001, are not necessarily
indicative of the results that can be expected for the year ending December
31, 2001.


                                     -3-

<PAGE>

                         ALTRIMEGA HEALTH CORPORATION
                         (Development Stage Company)
                                BALANCE SHEETS
                     June 30, 2001 and December 31, 2000

==============================================================================


                                                   Jun 30,       Dec 31,
                                                   2001          2000
                                                   ------------- -------------
ASSETS
CURRENT ASSETS
  Cash                                             $         49  $         33
                                                   ------------- -------------
      Total Current Assets                                   49            33
                                                   ------------- -------------

PROPERTY AND EQUIPMENT - net of accumulated               1,786         2,066
  depreciation - note 2                            ------------- -------------

ADVANCED DEPOSITS                                        20,000             -
                                                   ------------- -------------

                                                   $     21,835  $      2,099
                                                   ============= =============
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
  Note payable and accrued interest payable -      $     38,766  $      5,400
    related party - note 3
  Accounts payable                                          700         1,500
                                                   ------------- -------------
      Total Current Liabilities                          39,466         6,900
                                                   ------------- -------------

STOCKHOLDERS' EQUITY
  Preferred stock
    10,000,000 shares authorized at $0.001 par
    value ; none outstanding                                  -             -
  Common stock
    50,000,000 shares authorized at $0.001 par
    value; 22,020,000 shares issued and outstanding      22,020        22,020

  Capital in excess of par value                         74,980        74,980

  Deficit accumulated during the development stage     (114,631)     (101,801)
                                                   ------------- -------------

      Total Stockholders' Deficiency                    (17,631)       (4,801)
                                                   ------------- -------------

                                                   $     21,835  $      2,099
                                                   ============= =============


  The accompanying notes are an integral part of these financial statements.

                                     -4-
<PAGE>


                         ALTRIMEGA HEALTH CORPORATION
                         (Development Stage Company)
                           STATEMENTS OF OPERATIONS
      For the Three and Six Months Ended June 30, 2001 and 2000 and the
         Period September 8, 1998 (Date of Inception) to June 30, 2001

==============================================================================

                          Three Months          Six Months       Sept 8, 1998
                       Jun 30,    Jun 30,    Jun 30    Jun 30,        to
                        2001       2000       2001       2000    Jun 30, 2001
                     ---------- ---------- ---------- ---------- ------------

REVENUES             $       -  $   5,240  $       -  $   6,315  $     6,315

EXPENSES                 1,750     48,852     12,830     65,132      120,946
                     ---------- ---------- ---------- ---------- ------------

NET LOSS             $  (1,750) $ (43,612) $ (12,830) $ (58,817) $  (114,631)
                     ========== ========== ========== ========== ============
NET LOSS PER
 COMMON SHARE

  Basic              $       -  $       -  $       -  $       -
                     ---------- ---------- ---------- ----------
AVERAGE OUTSTANDING
 SHARES

  Basic
  (stated in 1000's)    22,020     22,020     22,020     22,020
                     ========== ========== ========== ==========


  The accompanying notes are an integral part of these financial statements

                                     -5-
<PAGE>

                         ALTRIMEGA HEALTH CORPORATION
                         (Development Stage Company)
                           STATEMENT OF CASH FLOWS
        For the Six Months Ended June 30, 2001 and 2000 and the Period
            September 8, 1998 (Date of Inception) to June 30, 2001

==============================================================================


                                      Jun 30        Jun 30     Sept 8,1998 to
                                      2001          2000       to Jun 30, 2001
                                      ------------ ----------- --------------
CASH FLOWS FROM OPERATING ACTIVITIES

  Net loss                            $   (12,830) $  (58,817) $    (114,631)

   Adjustments to reconcile net loss
   to net cash provided by operating
   activities

     Depreciation and amortization            280       6,866          1,014
     Changes in accounts payable           32,566      (1,500)        39,466
                                      ------------ ----------- --------------
     Net Cash Received (Used) in
     Operations                            20,016     (53,451)       (74,151)
                                      ------------ ----------- --------------

CASH FLOWS FROM INVESTING ACTIVITIES

   Purchase of equipment                        -           -         (2,800)
   Advance deposit - lease                (20,000)          -        (20,000)
                                      ------------ ----------- --------------
                                          (20,000)          -        (22,800)
                                      ------------ ----------- --------------
CASH FLOWS FROM FINANCING ACTIVITIES

   Proceeds from loan                           -           -              -
   Proceeds from issuance of common stock       -      50,500         97,000
                                      ------------ ----------- --------------

Net Increase (decrease)in Cash                 16      (2,951)            49

Cash at Beginning of Period                    33       4,125              -
                                      ------------ ----------- --------------

Cash at End of Period                 $        49  $    1,174  $          49
                                      ============ =========== ==============


  The accompanying notes are an integral part of these financial statements.

                                     -6-

<PAGE>

                         ALTRIMEGA HEALTH CORPORATION
                         (Development Stage Company)
                        NOTES TO FINANCIAL STATEMENTS

==============================================================================



1. ORGANIZATION

The Company was incorporated under the laws of the State of Nevada on
September 8, 1998 with the name of  Mega  International  Health  Corporation
with authorized common stock of 50,000,000 shares with a par value of $0.001
and preferred stock of 10,000,000 shares with a par value of $0.001. The board
of directors will determine the powers and rights of the preferred stock when
it is issued. On June 23, 1999 the name was changed to Altrimega Health
Corporation. On March 19,2001 the Company   completed a forward common stock
split of four shares for each outstanding share.  This report has been
completed showing after stock split shares from inception.

The Company was organized for the purpose of marketing nutritional products.

The Company is in the development stage.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Accounting Methods
------------------

The Company recognizes income and expenses based on the accrual method of
accounting.

Dividend Policy
---------------

The Company has not  adopted a policy regarding payment of dividends.

Property and Equipment
----------------------

The equipment consists of office furniture and equipment which is being
depreciated over 5  years.

Income Taxes
------------

On March 31, 2001 the Company  had   a  net operating loss carryforward   of
$114,631. The  tax benefit of $34,389 from the loss carry forward  has been
fully offset by a valuation reserve because the use of the future tax benefit
is doubtful, since the Company has no operations on which to project  future
net profits.

The loss carryover will expire in 2022.

Financial Instruments
---------------------

The carrying amounts of financial instruments, including cash and accounts
payable,  are considered by management to be their estimated fair values.

                                     -7-
<PAGE>

                         ALTRIMEGA HEALTH CORPORATION
                         (Development Stage Company)
                  NOTES TO FINANCIAL STATEMENTS (Continued)

==============================================================================


2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

Basic and Diluted Net Income (Loss) Per Share
---------------------------------------------

Basic net income (loss) per share amounts are computed based on the weighted
average number of shares actually outstanding. Diluted net income (loss) per
share amounts are computed using the weighted average number of common shares
and common equivalent shares outstanding as if shares had been issued on the
exercise of the preferred share rights unless the exercise becomes
antidilutive and then only the basic per share amounts are shown in the
report.

Estimates and Assumptions
-------------------------

Management uses estimates and assumptions in preparing financial statements in
accordance with generally accepted accounting principles.  Those estimates and
assumptions affect the reported amounts of the assets and liabilities, the
disclosure of contingent assets and liabilities, and the reported revenues and
expenses.  Actual results could vary from the estimates that were assumed in
preparing these financial statements.

Comprehensive Income
--------------------

The Company has adopted Statement of Financial Accounting Standards No. 130.
The adoption of this standard had no impact on the total stockholder's equity.

Other Recent Accounting Pronouncements
--------------------------------------

The Company does not expect that the adoption of other recent accounting
pronouncements to have any material impact on its  financial statements.

3. NOTE PAYABLE

The note payable consists of a no interest, demand loan, received from a
related party. Imputed interest at 8% has been included.

4. RELATED PARTY TRANSACTIONS

70% of the outstanding common stock was issued to a related parties.

                                     -8-

<PAGE>

                         ALTRIMEGA HEALTH CORPORATION
                         (Development Stage Company)
                  NOTES TO FINANCIAL STATEMENTS (Continued)

==============================================================================

5. GOING CONCERN

The company will need additional working capital to service its debt and for
its future planned activity and continuation of the Company as a going concern
is dependent upon obtaining sufficient working capital to be successful in
that effort and the management of the Company has developed a strategy, which
it believes will accomplish this objective through additional equity funding,
and long term financing, which will enable the Company to operate for the
coming year.



                                     -9-
<PAGE>

______________________________________________________________________________

     ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATIONS
______________________________________________________________________________

Overview
--------

The Company's plan of operation focuses on products which have been designed
as a result of the belief its natural medicines and nutritional supplements
offer a better alternative to traditional nutritional supplements currently
being produced by providing specialized combinations of nutrients. Prior to
the formation of Altrimega Health Corporation, an officer of the Company
completed the development of the Company's initial product line, and has
established relationships with suppliers of the various nutrients comprising
the Altrimega Health products. Additionally, the Company has established a
relationship with a Utah "contract" manufacturer, which will provide the
Company with product manufacturing, bottling and packaging.

The Company is now seeking to establish a distributor network with marketing
firms involved in the nutritional supplement industry throughout the country.
The Company also plans to undertake efforts to market its products through the
internet, various retail markets, including health food stores, and direct
sales through a toll-free number.

Proposed Activities
-------------------

As soon as  practicable, the Company plans to complete the manufacturing and
distributing arrangements with selected brokers in the industry, in different
regions of the country. At the same time, the Company will continue with
efforts to directly market its products to other retail markets. To the extent
the Company's funds allow, the Company will develop and market additional
nutritional products, to meet different special health needs and niche
markets.

Liquidity and Capital Resources
-------------------------------

As of June 30, 2001, the Company did not have sufficient assets to pay its
liabilities.

Results of Operations
---------------------

The Company is a development stage company and has had no operations during
the past quarter.

Liquidity and Capital Resources
-------------------------------

The Company will need additional working capital to finance its planned
activity.




                                     -10-
<PAGE>



PART II - OTHER INFORMATION


                             PART 2 - SIGNATURES

______________________________________________________________________________

                                  SIGNATURES
______________________________________________________________________________


Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned there unto duly authorized.


                                        Altrimega Health Corporation
                                        [Registrant]

                                        /s/ Howard Abrams
                                        ----------------------------------
                                        Howard Abrams - President
Dated July 19, 2001